DF Dent & Co. Inc. Cuts Holdings in HealthEquity, Inc. (NASDAQ:HQY)

DF Dent & Co. Inc. lessened its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 3.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 287,330 shares of the company's stock after selling 9,249 shares during the quarter. DF Dent & Co. Inc. owned about 0.33% of HealthEquity worth $27,569,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Wealthfront Advisers LLC purchased a new position in HealthEquity in the 4th quarter valued at about $10,304,089,000. Vanguard Group Inc. boosted its position in HealthEquity by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock worth $861,256,000 after purchasing an additional 99,624 shares during the period. State Street Corp grew its stake in shares of HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company's stock valued at $256,346,000 after buying an additional 23,613 shares in the last quarter. Geode Capital Management LLC grew its position in HealthEquity by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock valued at $200,522,000 after acquiring an additional 10,421 shares in the last quarter. Finally, Franklin Resources Inc. increased its stake in HealthEquity by 0.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock worth $139,369,000 after buying an additional 11,659 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Wall Street Analyst Weigh In

HQY has been the subject of a number of research reports. Barrington Research reaffirmed an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a report on Friday, March 14th. JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. KeyCorp cut their price objective on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Monday, March 24th. Royal Bank of Canada raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. Finally, Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $112.58.

Remove Ads

HealthEquity Stock Down 1.7 %

Shares of HQY stock traded down $1.40 during trading hours on Tuesday, hitting $78.96. 543,477 shares of the company's stock traded hands, compared to its average volume of 744,407. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The stock has a market cap of $6.83 billion, a price-to-earnings ratio of 72.53, a PEG ratio of 1.60 and a beta of 0.49. The stock's fifty day simple moving average is $101.18 and its two-hundred day simple moving average is $96.48.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.20% of the stock is owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.